pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis c after liver transplantation: from a canadian experience to recommendations for therapy
Clicks: 384
ID: 173900
2005
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
382 views
17 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
BACKGROUND: Recurrent hepatitis C (HCV) after liver transplantation (LT) is often more aggressive and treatments tend to be less successful. Pegylated-interferon and ribavirin are the standard of care for the treatment of HCV; however, there is limited published experience of its use after LT.
| Reference Key |
babatin2005canadianpegylated-interferon
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Mohamed Babatin;Lynn Schindel;Kelly W Burak |
| Journal | indian journal of pharmacology |
| Year | 2005 |
| DOI |
10.1155/2005/745197
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.